Join Our Team

Fortress Biotech, Inc. is a biopharmaceutical company dedicated to acquiring, developing, and commercializing novel pharmaceutical and biotechnology products and technologies.

Our employees’ broad background and experience creates an innovative and inspiring work environment which helps our staff focus on pioneering solutions to difficult questions in pharmaceutical development. If you have a passion for science, business development, and possess the desire and dedication to help others, look no further than Fortress Biotech to help you achieve your personal and professional goals.

Our Fortress Culture
As a member of our team, you will be part of a changing and continuously growing inclusive culture of excellence where you are encouraged to learn and grow. As an Equal Opportunity Employer, our capabilities and business practices are regularly transforming to include new and diverse ideas and people in order to cultivate and sustain a culturally diverse workforce.

Career Opportunities


Director of Investor Relations


Fortress Biotech, Inc. (“Fortress” or the “Company”) is an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates. Fortress is a commercial stage life sciences company with a robust development stage pipeline and  a uniquely scalable and risk-averse business model. It is the parent company to four public partner companies and seven additional private subsidiaries, all focused on drug development and commercialization. Fortress has equity ownership in the partner companies ranging from ~18% to 82%, potential royalty streams of 4.5% from most partner companies and annual equity dividends of 2.5% from most companies. The Company reported record net revenue in the first half of 2022 of $42.8 million, an increase of 45.5% versus the first half of 2021. In 2021, the total R&D spend on Fortress’ programs exceeded $150 million. However, the R&D spend at Fortress was only ~$6 million, with the balance being covered by partner companies Fortress controls as well as partners of partner companies. Additionally, in most instances through equity, royalties and milestones, Fortress anticipates 20-40% of the total economics/value of these programs within several quarters to a few years after product launch. 

Fortress has in-licensed and/or acquired 60 products and product candidates since 2014 and it has more than 20 full and part time search and evaluate team members continuously scouring the globe for drug development candidates and already marketed biopharma products. Fortress currently has eight marketed pharmaceutical products and 31 development stage programs including 20 clinical-stage programs in 31 clinical trials, of which four programs are in seven pivotal clinical trials. One Biologics Licensing Application filing is expected by January 2023 for a monoclonal antibody in oncology. Fortress aims to become a positive cash flow earnings company quickly through a diversified development and commercialization portfolio without taking single product risk. The Company focuses on scaling existing partner companies and the creation of new subsidiaries through efficient and targeted business development. Our R&D pipeline comes from the over 14,000 unique clinical stage drug candidates all over the world supported by over $350 billion in spending. We find many of these opportunities are unknown enough to be very inefficiently priced.

A recent example of the business model is when Fortress found and acquired CAEL-101 from a major U.S. medical research center, and on a $200,000 investment, the Company sold CAEL-101 to AstraZeneca in the fourth quarter of 2021 for $150 million upfront and an additional $350 million in potential regulatory and commercial milestones in coming years. Fortress receives ~42% of total proceeds.

We are looking for a motivated, resourceful and experienced life sciences investor relations professional who will be excited by and excel at communicating our uniquely scalable business model to both life science investors and non-life science equity investors – particularly those that would value a very broad and deeply diversified portfolio of development stage and marketed products. The Director of Investor Relations is a core part of the Fortress team and will also work collaboratively with our 11 controlled companies and their teams. The position requires knowledge of life sciences investor relations.


The position will be located in our Miami, FL office, and reports to the Chairman & CEO.


The Director of Investor Relations is responsible for organizing roadshows and communicating the organization’s position to/developing relations with appropriate institutional investors, brokers and media.

Duties and Responsibilities:

The essential functions of the role are below, but not limited to:

  • Partner with the company’s CEO in all aspects of Investor Relations activities
  • Work collaboratively with internal colleagues and external IR agencies in developing, implementing, and executing an investor strategic plan and communication strategy that drives an accurate understanding of the company story with the buy-side and sell-side
  • Manage investor outreach strategy and IR calendar, including coordination of roadshows, analyst interactions and professional/scientific meeting interactions with Wall Street
  • Strategize, pitch and coordinate participation in investor/banking/industry conferences
  • Contribute to development of company’s overall branding, differentiation, and identity within the life sciences community
  • Communicate frequently, proactively, and reactively, with institutional investors, research analysts and investment bankers
  • Conduct peer research, targeting and quarterly updating of target lists
  • Maintain active investor/analyst database of interactions with the financial community
  • Contribute to the process for preparation of/for corporate presentations, SEC filings, Board of Director meeting materials, annual shareholder meetings and annual report
    • Develop materials for meetings, quarterly calls, investor events and other disclosures, including key messages, presentations, conference call scripts, press releases, and Q&As
  • Monitor and analyze investor activity, stock price and volume trends, industry, and competitor developments to keep management team informed and prepare proactive and reactive plans as needed
  • Provide accurate, consistent, and timely responses to all external inquiries from investors and analysts


To perform the job successfully, an individual should demonstrate the following competencies to perform the essential functions of this position.

  • Communication skills – individual must demonstrate excellent interpersonal, verbal and written communication skills as well as exercise confidentiality.
  • Computer skills – individual must have working knowledge of Microsoft Office Suite and Nasdaq IR Insights (or similar investor relations platform).
  • Problem solving—the individual identifies and resolves problems in a timely manner, gathers and analyzes information skillfully.
  • Customer service—the individual manages difficult investor situations, responds promptly to investor needs, solicits feedback to improve service, responds to requests for service and assistance and meets commitments.
  • Planning/organizing—the individual prioritizes and plans work activities and uses time efficiently. This individual is extremely organized and detail oriented.
  • Quality control—the individual demonstrates accuracy and thoroughness, monitors own work to ensure quality and applies feedback to improve performance.
  • Quantity—meets productivity standards and completes work in a timely manner while managing multiple projects.
  • Adaptability—the individual adapts to changes in the work environment, prioritizes competing demands and is able to deal with frequent change, delays or unexpected events.
  • Dependability—the individual is consistently at work and on time, follows instructions, responds to management direction and solicits feedback to improve performance.

Position Type/Expected Hours of Work
This is a full-time position in our Miami, FL office.

Travel will be required up to 20% of the time.

Required Education and Experience

Bachelor’s degree or equivalent experience is required.
At least five years of previous experience in a related biotech or pharma investor relations role is preferred.
Must be able to work independently and complete projects with limited supervision, as well as to work as a member of a team.
Excellent interpersonal, verbal and written communication skills are required.


Compensation is commensurate with experience to include base salary, bonus potential, equity, and an attractive benefits package.

Fortress Biotech, Inc. is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability status, protected veteran status, or any other characteristic protected by applicable law.

Director of Investor Relations
Miami, FL:
Apply Now